# Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

> **NCT04174755** · NA · RECRUITING · sponsor: **University College Dublin** · enrollment: 80 (estimated)

## Conditions studied

- Obesity
- HIV-1-infection

## Interventions

- **DRUG:** Semaglutide Injectable Product
- **BEHAVIORAL:** Standard of care

## Key facts

- **NCT ID:** NCT04174755
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-22
- **Primary completion:** 2027-01
- **Final completion:** 2027-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04174755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04174755, "Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04174755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*